US President Donald Trump's freeze on foreign aid is likely to create a vacuum in Africa that China can exploit, but diplomatic analysts say it may not be an easy win for Beijing. The United States ...

Trump's foreign aid freeze is causing chaos in a system that, for over 20 years, has kept millions of people alive.

The progress made in HIV prevention and treatment over the last two decades has been transformative, but for many in Black America, the promise of these advances remains out of reach. We are now in a ...

The Federal Executive Council (FEC) has approved a N4.8 billion fund for the procurement of 150,000 HIV treatment packs, ensuring continuous care for those living with the virus. This decision ...

The State Department issued a waiver for lifesaving aid, but HIV clinics remain shut and uncertainty lingers over the future ...

The World Health Organisation (WHO) has appealed to the United States government to exempt HIV treatment from its current funding pause. In a statement published on its website, the global health ...

These include: life-saving HIV care and treatment services, including testing and counseling, prevention and treatment of infections including tuberculosis (TB), laboratory services, and ...

“We’re slowly achieving this target… where 85 percent of all people living with HIV (PLHIV) should be screened, 85 percent of those diagnosed should be on treatment, and 85 percent of those on ...

PEPFAR accounts for 17 percent of the country's HIV budget, ensuring some 5.5 million people receive anti-retroviral (ARV) treatment, according to the health ministry. "The US is a totally ...

The Federal Executive Council (FEC) of the Nigerian government on Tuesday approved N4.5 billion for the procurement of HIV treatment packs to support Nigerians living with HIV/AIDS. The approval ...

When growing gang violence and the kidnappings of healthcare workers forced Haiti’s leading organization in the treatment of HIV and AIDS-related illnesses to relocate operations from its main ...

ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. and Shionogi as shareholders, is pleased to announce it has successfully completed ...